The use of desensitizing agents during in-office bleaching might not decrease tooth bleaching sensitivity: a randomized clinical trial.


Journal

The international journal of esthetic dentistry
ISSN: 2198-591X
Titre abrégé: Int J Esthet Dent
Pays: Germany
ID NLM: 101624416

Informations de publication

Date de publication:
17 Feb 2022
Historique:
entrez: 17 2 2022
pubmed: 18 2 2022
medline: 22 2 2022
Statut: ppublish

Résumé

Due to controversial results in relation to the influence of desensitizing agents on sensitivity during bleaching, the present study evaluated the degree of tooth bleaching sensitivity, color change, and patient acceptability of desensitizing agents containing potassium nitrate/sodium fluoride (PNF) or nanostructured calcium phosphate (N) associated with in-office bleaching with 35% hydrogen peroxide (HP). Seventy-five patients were randomly distributed into three groups (n = 25): 1) Group W - in-office bleaching (Whiteness HP Maxx - three sessions of 45 min); 2) Group WD - associated with PNF desensitizing gel (Desensibilize KF 2%) applied for 10 min before each session; 3) Group WDN - associated with N desensitizing paste (Desensibilize Nano P) applied after bleaching for 5 min. The degree of sensitivity and patient acceptability of the desensitizing treatments were evaluated using a visual analog scale. Color change evaluations were made over different time intervals. The three groups showed no significant difference in sensitivity between the time intervals throughout the evaluation, except for the one of 24 h after the second bleaching session, in which group WD showed lower bleaching sensitivity than group W (P < 0.05; Kruskal-Wallis and Dunn tests). The use of PNF gel and N paste did not interfere with the color change during dental bleaching. Although the use of desensitizing agents during bleaching did not interfere with the color change during dental bleaching, it was shown that these agents were not effective in the treatment of tooth bleaching sensitivity, despite being acceptable to the patients.

Sections du résumé

BACKGROUND BACKGROUND
Due to controversial results in relation to the influence of desensitizing agents on sensitivity during bleaching, the present study evaluated the degree of tooth bleaching sensitivity, color change, and patient acceptability of desensitizing agents containing potassium nitrate/sodium fluoride (PNF) or nanostructured calcium phosphate (N) associated with in-office bleaching with 35% hydrogen peroxide (HP).
MATERIALS AND METHODS METHODS
Seventy-five patients were randomly distributed into three groups (n = 25): 1) Group W - in-office bleaching (Whiteness HP Maxx - three sessions of 45 min); 2) Group WD - associated with PNF desensitizing gel (Desensibilize KF 2%) applied for 10 min before each session; 3) Group WDN - associated with N desensitizing paste (Desensibilize Nano P) applied after bleaching for 5 min. The degree of sensitivity and patient acceptability of the desensitizing treatments were evaluated using a visual analog scale. Color change evaluations were made over different time intervals.
RESULTS RESULTS
The three groups showed no significant difference in sensitivity between the time intervals throughout the evaluation, except for the one of 24 h after the second bleaching session, in which group WD showed lower bleaching sensitivity than group W (P < 0.05; Kruskal-Wallis and Dunn tests). The use of PNF gel and N paste did not interfere with the color change during dental bleaching.
CONCLUSIONS CONCLUSIONS
Although the use of desensitizing agents during bleaching did not interfere with the color change during dental bleaching, it was shown that these agents were not effective in the treatment of tooth bleaching sensitivity, despite being acceptable to the patients.

Identifiants

pubmed: 35175011
pii: 2698031

Substances chimiques

Tooth Bleaching Agents 0
Hydrogen Peroxide BBX060AN9V

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-114

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH